Mantle cell lymphoma: At last, some hope for successful innovative treatment strategies

被引：13
作者：
Fisher, RI [1 ]
机构：
[1] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 04期
关键词：
D O I：
10.1200/JCO.2005.10.980
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：657 / 658
页数：2
相关论文
共 12 条
  • [1] Assouline S, 2003, BLOOD, V102, p902A
  • [2] MANTLE CELL LYMPHOMA - A PROPOSAL FOR UNIFICATION OF MORPHOLOGICAL, IMMUNOLOGICAL, AND MOLECULAR-DATA
    BANKS, PM
    CHAN, J
    CLEARY, ML
    DELSOL, G
    DEWOLFPEETERS, C
    GATTER, K
    GROGAN, TM
    HARRIS, NL
    ISAACSON, PG
    JAFFE, ES
    MASON, D
    PILERI, S
    RALFKIAER, E
    STEIN, H
    WARNKE, RA
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (07) : 637 - 640
  • [3] Chan WC, 1997, BLOOD, V89, P3909
  • [4] Dunleavy KM, 2003, BLOOD, V102, p636A
  • [5] A CLINICAL ANALYSIS OF 2 INDOLENT LYMPHOMA ENTITIES - MANTLE CELL LYMPHOMA AND MARGINAL ZONE LYMPHOMA (INCLUDING THE MUCOSA-ASSOCIATED LYMPHOID-TISSUE AND MONOCYTOID B-CELL SUBCATEGORIES) - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    FISHER, RI
    DAHLBERG, S
    NATHWANI, BN
    BANKS, PM
    MILLER, TP
    GROGAN, TM
    [J]. BLOOD, 1995, 85 (04) : 1075 - 1082
  • [6] European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma
    Foran, JM
    Rohatiner, AZS
    Cunningham, D
    Popescu, RA
    Solal-Celigny, P
    Ghielmini, M
    Coiffier, B
    Johnson, PWM
    Gisselbrecht, C
    Reyes, F
    Radford, JA
    Bessell, EM
    Souleau, B
    Benzohra, A
    Lister, TA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) : 317 - 324
  • [7] Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-Cell non-Hodgkin's lymphoma
    Goy, A
    Younes, A
    McLaughlin, P
    Pro, B
    Romaguera, JE
    Hagemeister, F
    Fayad, L
    Dang, NH
    Samaniego, F
    Wang, M
    Broglio, K
    Samuels, B
    Gilles, F
    Sarris, AH
    Hart, S
    Trehu, E
    Schenkein, D
    Cabanillas, F
    Rodriguez, AM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) : 667 - 675
  • [8] HIDDEMANN W, 2004, P AN M AM SOC CLIN, V23, P556
  • [9] Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: Molecular complete responses are not predictive of progression-free survival
    Howard, OM
    Gribben, JG
    Neuberg, DS
    Grossbard, M
    Poor, C
    Janicek, MJ
    Shipp, MA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1288 - 1294
  • [10] Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma
    Khouri, IF
    Romaguera, J
    Kantarjian, H
    Palmer, JL
    Pugh, WC
    Korbling, M
    Hagemeister, F
    Samuels, B
    Rodriguez, A
    Giralt, S
    Younes, A
    Przepiorka, D
    Claxton, D
    Cabanillas, F
    Champlin, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3803 - 3809
12